Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DNLI - Denali Therapeutics gets FDA review extension for tividenofusp alfa

DNLI - Denali Therapeutics gets FDA review extension for tividenofusp alfa

October, 13 2025 04:31 PM Denali Therapeutics Inc.

2025-10-13 16:31:56 ET

More on Denali Therapeutics

Denali Therapeutics Inc. (DNLI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Goldman's 48 potential M&A candidates
Seeking Alpha’s Quant Rating on Denali Therapeutics
Historical earnings data for Denali Therapeutics
Financial information for Denali Therapeutics

For further details see:

Denali Therapeutics gets FDA review extension for tividenofusp alfa

Stock Information

Company Name:	Denali Therapeutics Inc.
Stock Symbol:	DNLI
Market:	NASDAQ
Website:	denalitherapeutics.com

DNLI DNLI Quote DNLI Short DNLI News DNLI Articles DNLI Message Board

Get DNLI Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.